Target Organs and Levels of Evidence for TR-493
Toxicology and Carcinogenesis Studies of Emodin (CASRN 518-82-1) in F344/N Rats and B6C3F1 Mice (Feed Studies)
| Chemical (Study Title) CASRN | Peer Review Date | Route/Exposure Levels | Study Laboratory | 
|---|---|---|---|
| Emodin 518-82-1 | 05/21/1999 | Dosed-Feed R: 0, 280, 830, OR 2500 PPM; 60/SEX M: 0, 160, 312, 625, OR 1250 PPM; 60/SEX | Southern Research Institute | 
Levels of Evidence
Male Rats: No Evidence
| Type | Organ/Tissue (Lesion) | 
|---|---|
| Non-Neoplastic Lesions | 
 | 
| Other Considerations | 
 | 
Female Rats: Equivocal Evidence
| Type | Organ/Tissue (Lesion) | 
|---|---|
| May Have Been Related | 
 | 
| Non-Neoplastic Lesions | 
 | 
| Other Considerations | 
 | 
Male Mice: Equivocal Evidence
| Type | Organ/Tissue (Lesion) | 
|---|---|
| May Have Been Related | 
 | 
| Non-Neoplastic Lesions | 
 | 
Female Mice: No Evidence
| Type | Organ/Tissue (Lesion) | 
|---|---|
| Non-Neoplastic Lesions | 
 | 

